Despesas De Vendas E Administração Alterar Data
Adma Biologics USD 26.74M 6.55M 2026-03
Alnylam Pharmaceuticals USD 347.92M 65.41M 2026-06
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Novavax USD 25.53M 1.34M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Takeda JPY 286.51B 5.48B 2026-06